Beilstein J. Nanotechnol. 2019, 10, 1707–1715. https://doi.org/10.3762/bjnano.10.166
Doxorubicin IC50s in neuroblastoma cells in the absence or presence of the ABCB1 inhibitor zosuquidar. Effects of doxorubicin applied as solution or incorporated into HSA nanoparticles on neuroblastoma cell viability. Effects of doxorubicin solution or doxorubicin HSA nanoparticles on neuroblastoma cells with or without zosuquidar.
Supporting Information File 1: Additional experimental details. | ||
Format: PDF | Size: 69.4 KB | Download |
Article Citation | |
Download RIS (Reference Manager) | Download BIB (BIBTEX) |
Cited References | |
Download RIS (Reference Manager) | Download BIB (BIBTEX) |
Picture with graphical abstract, title and authors for social media postings and presentations.
Format: PNG | Size: 880.9 KB | Download |
Matthias G. Wacker